GeneSight. (n.d.). Get to know a gene: COMT. Retrieved August 17, 2025, from https://genesight.com/white-papers/get-to-know-a-gene-comt/

Huang, E., Zai, C. C., Lisoway, A., Maciukiewicz, M., Felsky, D., Tiwari, A. K., Bishop, J. R., Ikeda, M., Molero, P., Ortuño, F., ... Kennedy, J. L. (2016). Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: A meta-analysis. International Journal of Neuropsychopharmacology, 19(5), pyv132. https://doi.org/10.1093/ijnp/pyv132

Nicotera, A. G., Di Rosa, G., Turriziani, L., Costanzo, M. C., Stracuzzi, E., Vitello, G. A., Galati Rando, R., Musumeci, A., Vinci, M., Musumeci, S. A., & Calì, F. (2021). Role of COMT V158M polymorphism in the development of dystonia after administration of antipsychotic drugs. Brain Sciences, 11(10), 1293. https://doi.org/10.3390/brainsci11101293

Spiros, A., & Geerts, H. (2021). Toward predicting impact of common genetic variants on schizophrenia clinical responses with antipsychotics: A quantitative system pharmacology study. Frontiers in Neuroscience, 15, 738903. https://doi.org/10.3389/fnins.2021.738903